Detalhe da pesquisa
1.
Role of red cell mass evaluation in myeloproliferative neoplasms with splanchnic vein thrombosis and normal hemoglobin value: a study of the France Intergroupe des Syndromes myeloprolifératifs.
Haematologica
; 2024 02 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-38328854
2.
Comparative clinical and molecular landscape of primary and secondary myelofibrosis: Superior performance of MIPSS70+ v2.0 over MYSEC-PM.
Am J Hematol
; 99(4): 741-744, 2024 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-38279562
3.
Reduced murine double minute 2 and 4 protein, but not messenger RNA, expression is associated with more severe disease in myelodysplastic syndromes and acute myeloblastic leukaemia.
Br J Haematol
; 201(2): 234-248, 2023 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-36546586
4.
Dasatinib plus Peg-Interferon alpha 2b combination in newly diagnosed chronic phase chronic myeloid leukaemia: Results of a multicenter phase 2 study (DASA-PegIFN study).
Br J Haematol
; 200(2): 175-186, 2023 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36214090
5.
p53 activation during ribosome biogenesis regulates normal erythroid differentiation.
Blood
; 137(1): 89-102, 2021 01 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-32818241
6.
Revisiting Diagnostic performances of serum erythropoïetin level and JAK2 mutation for polycythemias: analysis of a cohort of 1090 patients with red cell mass measurement.
Br J Haematol
; 196(3): 676-680, 2022 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-34562020
7.
Insights into the Potential Mechanisms of JAK2V617F Somatic Mutation Contributing Distinct Phenotypes in Myeloproliferative Neoplasms.
Int J Mol Sci
; 23(3)2022 Jan 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-35162937
8.
Should Transplantation Still Be Considered for Ph1-Negative Myeloproliferative Neoplasms in Transformation?
Biol Blood Marrow Transplant
; 26(6): 1160-1170, 2020 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-32119970
9.
Synergistic effects of PRIMA-1Met (APR-246) and 5-azacitidine in TP53-mutated myelodysplastic syndromes and acute myeloid leukemia.
Haematologica
; 105(6): 1539-1551, 2020 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-31488557
10.
Longer treatment duration and history of osteoarticular symptoms predispose to tyrosine kinase inhibitor withdrawal syndrome.
Br J Haematol
; 187(3): 337-346, 2019 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-31271217
11.
Next-generation sequencing for JAK2 mutation testing: advantages and pitfalls.
Ann Hematol
; 98(1): 111-118, 2019 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-30259120
12.
Impact of NFE2 mutations on AML transformation and overall survival in patients with myeloproliferative neoplasms.
Blood
; 138(21): 2142-2148, 2021 11 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-33945619
13.
Non-adherence to treatment with cytoreductive and/or antithrombotic drugs is frequent and associated with an increased risk of complications in patients with polycythemia vera or essential thrombocythemia (OUEST study).
Haematologica
; 103(4): 607-613, 2018 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-29246923
14.
Emergence of MPLW515 mutation in a patient with CALR deletion: Evidence of secondary acquisition of MPL mutation in the CALR clone.
Hematol Oncol
; 36(1): 336-339, 2018 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-28556926
15.
Second tyrosine kinase inhibitor discontinuation attempt in patients with chronic myeloid leukemia.
Cancer
; 123(22): 4403-4410, 2017 Nov 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-28743166
16.
Clinical and molecular response to interferon-α therapy in essential thrombocythemia patients with CALR mutations.
Blood
; 126(24): 2585-91, 2015 Dec 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-26486786
17.
Lack of Transcription Factor p53 Exacerbates Elastase-Induced Emphysema in Mice.
Am J Respir Cell Mol Biol
; 54(2): 188-99, 2016 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-26106979
18.
In vitro assessment of the sensitivity to APR-246 + azacitidine combination predicts response to this combination in myelodysplastic/acute myeloid leukaemia patients.
Br J Haematol
; 194(4): e77-e79, 2021 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-34145569
19.
JAK2 and MPL protein levels determine TPO-induced megakaryocyte proliferation vs differentiation.
Blood
; 124(13): 2104-15, 2014 Sep 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-25143485
20.
CCND2 mutations are infrequent events in BCR-ABL1 negative myeloproliferative neoplasm patients.
Haematologica
; 106(3): 863-864, 2021 03 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32414847